Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA. J of Skin. 2024;8(6):s471. doi:10.25251/skin.8.supp.471